Protein Delivery Devices

• Healthcare Professionals
•  
• Patients
•  
• Investors
•  
• Media
•  
• R&D
•  
• Jobs
•  
• Sustainability
•  
• About us

• R&D at a glance
• About R&D
• Pipeline
• Partnering
  • Why partner with us?
  • Being partner with us
  • Diabetes
  • Protein Delivery
  • Haemophilia
  • Growth disorders
  • Inflammation
  • Partnerships
  • Protein expertise
  • Clinical research partnerships
  • Novo Nordisk Biotech Fund
  • Contact us
• Scientific publications
• Bioethics
• From idea to patient
• Fellowships
• Novo Nordisk Trials
• Contact us

• 
• Print

Protein Delivery Devices

Our history in devices

In 1985, Novo Nordisk introduced the world’s first insulin pen. The insulin pen gave people with diabetes a convenient device to inject insulin several times a day. Since then, we have made extensive efforts in research and development of new delivery systems which will help people with chronic diseases manage protein therapy.

Our partnering focus

New injection device concepts and technologies

• Injection of soluble protein formulations
• Injection of lyophilised protein formulations

New infusion device concepts and technologies

• Subcutaneous insulin infusion
• Intravenous infusion for haemophilia therapy

New primary packaging concepts and technologies

For other enquiries

Contact

For further information please contact Diabetes Sourcing & Strategy

Download

Please download the Novo Nordisk:
Partnering folder

Back to top